PI3K/mTOR Dual Inhibitor PF-04691502 Is a Schedule-Dependent Radiosensitizer for Gastroenteropancreatic Neuroendocrine TumorsZeta Chow(The Ohio State University), Piotr Rychahou(Markey Cancer Center)CellsMay 20, 202110.3390/cells10051261Cited by 20SaveCiteExport RISWatch citationsRelated PapersTargeting Plk1 Sensitizes Pancreatic Cancer to Immune Checkpoint Therapy|Cancer Research|2022|68Inhibition of ribonucleotide reductase subunit M2 enhances the radiosensitivity of metastatic pancreatic neuroendocrine tumor|Cancer Letters|2024|8